Crop Life Science Balans Gezondheid
Financiële gezondheid criteriumcontroles 2/6
Crop Life Science has a total shareholder equity of ₹717.4M and total debt of ₹297.6M, which brings its debt-to-equity ratio to 41.5%. Its total assets and total liabilities are ₹1.7B and ₹1.0B respectively. Crop Life Science's EBIT is ₹94.2M making its interest coverage ratio 2.8. It has cash and short-term investments of ₹5.8M.
Belangrijke informatie
41.5%
Verhouding schuld/eigen vermogen
₹297.63m
Schuld
| Rente dekkingsratio | 2.8x |
| Contant | ₹5.77m |
| Aandelen | ₹717.45m |
| Totaal verplichtingen | ₹1.01b |
| Totaal activa | ₹1.73b |
Recente financiële gezondheidsupdates
Analyse van de financiële positie
Kortlopende schulden: CLSL's short term assets (₹1.4B) exceed its short term liabilities (₹917.9M).
Langlopende schulden: CLSL's short term assets (₹1.4B) exceed its long term liabilities (₹89.8M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: CLSL's net debt to equity ratio (40.7%) is considered high.
Schuld verminderen: Insufficient data to determine if CLSL's debt to equity ratio has reduced over the past 5 years.
Schuldendekking: CLSL's operating cash flow is negative, therefore debt is not well covered.
Rentedekking: CLSL's interest payments on its debt are not well covered by EBIT (2.8x coverage).